Form D — Dravite Therapeutics, Inc.
0001231919-26-001141 · filed Sep 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $52,999,992
- Reported amount sold
- $52,999,992
- Minimum investment
- $0
- Investors
- 11
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Dravite Therapeutics, Inc.
- CIK
- 2133272
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 401 CAMBRIDGE STREET
SAN FRANCISCO, CA 94134 - Phone
- 510-920-4145
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JOSEPH SUM · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
SANDEEP KULKARNI · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
BARBARA KOSACZ · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
MATTHEW MOORE · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
JEREMY GOLDBERG · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
RISHI GUPTA · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗